Jeffrey D. Bloss
CIK: 0001807569
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)0 (0.0%)
Compensation grants
Other (G, F, J, C, D, …)1 (100.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
NCNA
NuCana plc
Officer
Discretionary Trading P&L
Holdings
About Bloss Jeffrey D.
Bloss Jeffrey D. (SEC CIK 0001807569) files insider reports with the SEC as Chief Medical Officer of NuCana plc (NCNA).
Signal8 holds 2 ownership filings by Bloss Jeffrey D. (1 Form 3, 1 Form 4), filed between Mar 19, 2026 and Jun 23, 2026. Those filings report 1 transaction, the latest on Jun 19, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Bloss Jeffrey D.'s filings is in EDINBURGH.
Recent filings by Bloss Jeffrey D.
- Jun 19, 2026: Disposition to issuer transaction of NCNA derivative securities (Form 4, code D).
Other insiders filing for NuCana plc (NCNA)
- Levy Elliott M., Director
- Bruce Theresa Margaret Ms, Chief Operating Officer
- Harrison David James, Head of Translational Medicine
- Mellish Martin C.B., Director
- Webster Ian Alexander
- Kay Andrew Martin, Director